{"id":"W4388586208","doi":"10.1093/bjd/ljad429","title":"Bimekizumab safety in patients with moderate-to-severe plaque psoriasis: pooled data from up to 3 years of treatment in randomized phase III trials","year":2023,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"UCB Pharma; LEO Pharma; Sun Pharma; Eisai; National Institute for Health and Care Research; Manchester Biomedical Research Centre; Eli Lilly and Company; Bristol-Myers Squibb; Amgen","keywords":"Medicine; Discontinuation; Adverse effect; Psoriasis; Incidence (geometry); Internal medicine; Plaque psoriasis; Gastroenterology; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001318874,0.0005734579,0.01078785,0.001153096,0.00005746792,0.00003182063,0.0008786675,0.0008042734,0.0001801182],"category_scores_gemma":[0.001057318,0.0004823875,0.0007013626,0.0006198752,0.0001055534,0.0001600958,0.0002082972,0.0004543422,0.0001323321],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003139139,"about_ca_system_score_gemma":0.001126645,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001342168,"about_ca_topic_score_gemma":0.001524824,"domain_scores_codex":[0.9896356,0.004982242,0.004070531,0.0006511743,0.0001213591,0.000539057],"domain_scores_gemma":[0.9939734,0.003041857,0.002111167,0.000615198,0.0001510877,0.0001073172],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1709498,0.001031992,0.00007857908,0.0003191832,0.007886634,0.002170968,0.0003826898,0.00001196188,0.000002543751,0.000006866869,0.001413503,0.8157453],"study_design_scores_gemma":[0.8731532,0.0009679885,0.000349011,0.02030831,0.009179994,0.004074418,0.0001307803,0.000002075423,0.00005211462,0.00006428121,0.09088277,0.0008351338],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.08987184,0.8990483,0.00006259134,0.00005422531,0.001538758,0.003519624,0.005866043,0.00002035843,0.00001830097],"genre_scores_gemma":[0.01254883,0.9824972,0.0002065107,0.00003239606,0.00006967348,0.0001996485,0.004232796,0.00008630766,0.0001266098],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8149102,"threshold_uncertainty_score":0.9997628,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06127394202515896,"score_gpt":0.3284469304501376,"score_spread":0.2671729884249786,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}